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A B S T R A C T
The influence of apolipoprotein E (ApoE) genotypes on plasma lipid levels and interaction with other environmental
factors was determined in two Slovakian population samples; 146 Romany and 351 Slovak individuals. The two sam-
ples differ significantly in the distribution of E3/3 genotypes (p0.014) and E3/2 (p0.035). Analysis of variance did not
reveal any significant effect of the ApoE genotypes on any of the plasma lipid levels in the Romany individuals. In the
Slovak sample the variation in plasma low-density lipoprotein cholesterol (LDL-C) levels was significantly associated
with the ApoE genotypes (p=0.012). We detected decreased LDL-C concentrations in males with E2 genotype when com-
pared with E3 and E4 carriers (p=0.008). Further, the E2 genotype was found to be associated with high triglycerides
levels (p=0.009). The ethnic samples differ significantly in the prevalence of metabolic syndrome and in the case of males
of diabetes. Both the Romany and the Slovak males can be considered as having a more atherogenic profile compared
with the females.
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Introduction
Apolipoprotein E (ApoE) plays a central role in lipid
metabolism as a ligand for two cell-surface lipoprotein
receptors, which mediate the cellular uptake of specific
lipoproteins such as intermediate-density lipoprotein
and chylomicron remnants1. The ApoE gene has three
common alleles2, ApoE*2, ApoE*3 and ApoE*42, the fre-
quencies of which differ significantly among diverse eth-
nic groups3–6. Despite the wide variation observed in al-
lele frequency distribution, ApoE*3 was found to be the
most common allele. Intensive investigations have estab-
lished that allele variation in the ApoE gene has a signifi-
cant effect on interindividual variation in total choles-
terol (TC) and low-density lipoprotein cholesterol (LDL-
C) levels and on risk of cardiovascular disease in the gen-
eral population7–9.
The Slovak population occupies the upper part of the
cardiovascular mortality scale10. Although in the last few
years there seems to be a slight decrease11 it does not
substantially change the Slovak position as compared to
other countries with active atherosclerosis prevention
programs. Thus, the study of factors that are involved in
the aetiology of cardiovascular disease is very topical.
Some studies dealing with genetic and environmental
risk factor contributions to the development of coronary
atherosclerosis in families with and without history of
early myocardial infarction have already been conduc-
ted12–15. However, in the general population and the Ro-
many, the second most numerous Slovak minority, data
regarding genetic polymorphisms and their relationships
with plasma lipid levels are scarce16,17. Although no offi-
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cial statistics exist, available data suggest that poor
health status, morbidity and total premature mortality
in the Romany are probably three times as prevalent as
in the general Slovak population18. The majority of stud-
ies on genetic markers in different Romany samples from
Slovakia showed that their gene pool differs significantly
from the Slovak population and that gene frequencies
of several genetic markers are close to some Indian popu-
lation groups19. However, conclusive heterogeneity exists
among different Romany groups in Slovakia as well as di-
versification on the European scale20. Keeping this in
view, the aim of this article is to compare these two popu-
lation samples with respect to distribution of ApoE geno-
types and frequencies, to estimate if different ApoE ge-
notypes could influence the plasma lipid and lipoprotein
levels and to analyse the interaction with other variables
associated with coronary risk factors.
Materials and Methods
Study subjects
Romany subjects were inhabitants of the village Zlaté
Klasy with a large Roma community, situated close to the
capital city Bratislava. At the time of data collection, of
the total of 3,322 inhabitants, nearly 50 percent were Ro-
many subjects. A sample of 150 adult volunteers (68 ma-
les and 82 females) was recruited and interviewed during
medical examination. Trained anthropologists collected
data. The sample is representative of the general Ro-
many population with the inbreeding coefficient from ge-
nealogy equal to 0.00016.
Three hundred and fifty one Slovak subjects (174 men
and 177 women), were participants of the CINDI (Coun-
trywide Integrated Noncommunicable Diseases Inter-
vention) survey from Banská Bystrica (Middle Slova-
kia)21. The collected data were provided for further pro-
cessing and the ApoE polymorphism was detected chro-
nologically at the same laboratory, by one of the co-au-
thors. The data collection had similar design in both
studies.
Anthropometric measurements (body weight and height,
circumference of waist and hips) were taken along with
medical examination. Body mass index (BMI) was calcu-
lated as body weight divided by height squared and waist
to hip ratio (WHR) was calculated as the circumference
of the waist divided by the circumference of hips.
Blood samples were collected in EDTA vacutainers.
Plasma total cholesterol and triglycerides levels were de-
termined using enzymatic methods, high-density lipo-
protein cholesterol (HDL-C) was measured by dextran
sulphate precipitation, and low density lipoprotein cho-
lesterol (LDL-C) was calculated using the formula of
Friedewald et al.22. The atherogenic indices considered
were the ratio of TC/HDL-C and logarithm of ratio (TG/
HDL-C)23.
DNA was isolated from peripheral blood leukocytes
by the standard phenol extraction technique. The ApoE
genotypes were determined by polymerase chain reac-
tion (PCR) using the following primers:
5´ – GGC CCAGGC CCGGCTGGGCGCGGA – 3´
5´ – CGG ATGGCG CTG AGGCCG CGC TCG – 3´
The amplified DNA was cleaved with HhaI followed
by electrophoresis on a polyacrylamide gel24.
Blood pressure was measured twice in the sitting po-
sition after 10 minutes of rest using a mercury sphygmo-
manometer. Subjects with hypertension were selected ac-
cording to blood pressure (systolic >155 mmHg and/or
diastolic >95 mmHg). Subjects with diabetes mellitus
(DM) were selected according to level of glucose>7mmol/L.
Metabolic syndrome (MS) defined by the National
Cholesterol Education Program Adult Treatment Panel
III (NCEP ATP III)25, represents a clustering of risk fac-
tors and is diagnosed when three or more indicators are
present. Inclusion criteria were the following: abdominal
obesity: waist: 102 cm males, 88 cm females, hypertri-
glyceridemia: 1.7 mmol/L, HDL-C: males 	1.0 mmol/L,
females 	1.3 mmol/L, blood pressure: 130/85 mmHg,
fasting glycaemia: 6.1 mmol/L.
Education was classified into three categories, namely
elementary, apprentice and higher education.
The normal distribution of examined parameters was
tested by the Kolmogorov-Smirnov test and Shapiro-Wilk
test. Differences between the quantitative parameters
were compared by Student’s t test or by Mann-Whitney
test for parameters that showed non-normal distribu-
tion. Allele frequencies were tested for the Hardy-Wein-
berg equilibrium. Mean adjusted lipid levels were com-
pared among ApoE genotype groups using analysis of
variance (ANOVA) or Kruskal-Wallis tests. For this pur-
pose subjects were grouped as ApoE2 carriers (ApoE 2/2
and ApoE 2/3 genotypes), ApoE3 carriers (ApoE 3/3 ge-
notype) and ApoE4 carriers (ApoE 3/4 and ApoE 4/4 ge-
notypes). The regression analysis was performed to esti-
mate the effect of apoE alleles and other risk factors like
age, sex, ethnicity, BMI, WHR and education on plasma
lipid levels.
These analyses were performed using SPSS (version
13.0) for Windows.
The Ethics Committee of the Institute of Preventive
and Clinical Medicine (Bratislava) approved the study.
Results and Discussion
Characteristics of the two population samples by sex
are given in Table 1. Both males and females of these
samples differ significantly in mean age. It is interesting
to note that the Roma subjects, being younger than the
Slovaks, are significantly shorter in their body height.
The variables related to obesity (BMI and WHR indices)
show very high average values in both groups and signifi-
cant differences between the groups. A majority of the
Slovak subjects, both males and females, were character-
ized by BMI as overweight, while most Roma subjects
can be characterized as obese. In the Romany sample






















































































Age (years) 46.2 (45.0–47.4) 39.9 (36.8-42.9) *** 47.7 (46.4–49.0) 41.3 (37.9–44.7) **
Weight (kg) 70.6 (68.6–72.6) 75.3 (70.8–79.7) ns 83.4 (81.6–85.2) 89.1 (84.8–93.5) *
Height (cm) 164.0 (163.1–164.0) 159.5 (158.3–160.8) *** 175.1 (174.1–176.1) 171.9 (170.4–173.4) **
BMI (kg/m2) 26.3 (25.5–27.0) 29.6 (27.9–31.3) ** 27.2 (26.6–27.8) 30.1 (28.8–31.5) ***
WHR 80.2 (79.3–81.2) 86.2 (84.3–88.1) *** 89.8 (89.0–90.7) 96.5 (94.6–98.3) ***
SBP (mmHg) 129.3 (125.8–132.7) 124.3 (119.2–129.4) ns 137.3 (134.0–140.7) 130.1 (124.6–135.6) ns
DBP (mmHg) 82.7 (80.8–84.6) 76.7 (73.9–79.6) ** 87.4 (85.6–89.2) 81.4 (78.6–84.2) **
Glucose (mmol/L) 5.3 (5.9–0.6) 5.3 (4.9–6.7) ns 5.4 (5.2–5.5) 6.3 (5.6–7.0) ns
TC (mmol/L) 5.9 (5.7–6.2) 4.8 (4.5–5.0) *** 5.8 (5.6–6.0) 5.1 (4.7–5.4) ***
LDL-C (mmol/L) 3.7 (3.5–3.8) 3.0 (2.8–3.1) *** 3.5 (3.4–3.7) 3.0 (2.8–3.2) ***
HDL-C (mmol/L) 1.5 (1.5–1.6) 1.1 (1.1–1.2) *** 1.3 (1.3–1.4) 1.0 (1.0–1.1) ***
TG (mmol/L) 1.6 (1.3–1.9) 1.5 (1.3–1.7) ns 2.2 (1.9–2.5) 2.6 (1.8–3.4) ns
log(TG/HDL-C) –0.05 (–0.09–(–0.003)) 0.08 (0.03–0.14) ** 0.11 (0.05–0.16) 0.26 (0.16–0.35) **
TC/HDL 4.4 (3.7–5.0) 4.3 (4.1–4.6) ns 4.7 (4.5–4.9) 5.2 (4.7–5.7) *
MS 41 (23.3%) 28 (36.8%) * 39 (23.1%) 30 (44.8%) **
Hypertention 34 (19.2%) 14 (17.9%) ns 49 (28.2%) 12 (17.6%) ns
Diabetes Mellitus 10 (5.6%) 6 (7.3%) ns 7 (4.0%) 15 (22.1%) ***
Education
– elementary 17 (9.6%) 61 (78.2%) *** 10 (5.8%) 40 (58.8%)
***
– apprentice 129 (72.9%) 17 (21.8%) *** 122 (70.5%) 28 (41.2%) ***
– higher education 31 (17.5%) 0 0 *** 41 (23.7%) 0 0 ***
BMI – body mass index, WHR – waist to hip ratio, SBP – systolic blood pressure, DBP – diastolic blood pressure, TC – total cholesterol, LDL-C – low-density lipoprotein cholesterol,
HDL-C – high-density lipoprotein cholesterol, TG – triglycerides, TC/HDL-C and log(TG/HDL-C) – atherogenic indices, MS – metabolic syndrome, *p<0.05, **p<0.01, ***p<0.001
52.7% of individuals were obese (BMI30.0) vs. 22.1% of
all Slovak persons. Both the Romany females and males
differed significantly from the Slovaks in the average val-
ues of central obesity index (WHR). In 32% of Roma peo-
ple vs. 5.5% of Slovaks the WHR index borders on a need
for health care and suggests an androgynous type of fat
distribution, which is more dangerous from the athero-
genic point of view.
The mean values of diastolic blood pressure, TC,
LDL-C and HDL-C were significantly higher in the Slo-
vak females and males, respectively, than in the Romany
individuals. The mean plasma atherogenic index (ex-
pressed as log TG/HDL-C) is significantly lower among
the Slovak females and males than in the Roma individu-
als.
The mean value of another index of plasma lipids
(TC/HDL-C) differs significantly only between males of
the two groups, and is lower in Slovaks. Further, we have
found that the prevalence of MS is significantly different
between these ethnic samples and higher in the Slovak
females and males than in the Romany subjects. The
male series also differ in prevalence of DM (Romany
males 22.05% vs. Slovak males 4.0%). No significant dif-
ferences have been observed between the ethnic samples
with respect to prevalence of hypertension.
The ethnic samples differ significantly in the level of
education. The Romany had only elementary and ap-
prentice education and differ significantly from the Slo-
vaks, among whom 17.5% of females and 23.7% of males
had higher education, in addition.
The observed values of BMI and WHR indices in the
Romany subjects are much higher than those found in
the Slovak patients who survived premature myocardial
infarction14. The observed high mean values of both the
obesity indices are not symptomatic only for the present
study. Similar results were published in the study of
adult population from Bratislava26. Among adult partici-
pants of the MONICA study from Middle Slovakia over-
weight by BMI was reported in 52.4% of females and
69.1% of males27. The only study from Slovakia28, which
examined lipid and non-lipid cardiovascular risk parame-
ters in a young Gypsy population, showed significant
prevalence of obesity among them (20% of Romany sub-
jects had BMI30.0 vs 8% of Slovak subjects). These
young individuals had a significantly decreased HDL-C
level and significantly higher values of TG and athero-
genic index expressed as ratio TC/HDL-C than the young
Slovaks. These findings are not in conformity with our
results except for the decreased HDL-C level found in the
Romany subjects. Particularly the atherogenic index (TC/
HDL-C) in our study gives contradictory result. How-
ever, our Roma subjects had significantly higher values
of another plasma parameter calculated as log(TG/HDL-C).
This index was recently suggested, among the other new
indicators of atherogenic risk23, as a more precise mea-
sure of atherogenic profile of plasma examined in a large
sample of Czech and Slovak subjects and compared with
the French PRIME study and the Canadian HATS study.
ApoE allele and genotype frequencies observed in
both samples are presented in Table 2. Hardy-Weinberg
equilibrium can be assumed only for the Slovak sample
(Slovak 2=6.48, df 3, Romany 2=39.88, df 3). The two
samples do not differ significantly in the gene frequen-
cies (p=0.181). Neither female nor male series are not
significantly different in the gene frequencies (females
p=0.720, males p=0.161)). However, these samples differ
significantly in the distribution of particular genotypes
(p=0.04). The same results were obtained when only the
three most frequent genotypes in both samples (E3/2,
E3/3, E4/3), were compared (2=8.9, df 2, p=0.012). In
the Romany sample significantly more homozygous E3/3
(p=0.035) and fewer E3/2 heterozygous genotypes (p=
0.014) were observed than in the Slovak sample. In addi-
tion, we have tested the ratio of »protective« (E2/2, E2/3)
and »atherogenic« (E4/4, E3/4) genotypes in each sample,
respectively, but this did not show any significant differ-
ence.
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TABLE 2
APOE ALLELE AND GENOTYPE FREQUENCIES IN TWO SAMPLES FROM SLOVAKIA
Slovak sample N=351 Romany sample N=146
Allele Males Females All Males Females All
ApoE*2 0.0718 0.0678 0.0698 0.0303 0.0563 0.0445
ApoE*3 0.8477 0.8616 0.8547 0.9091 0.8875 0.8973
ApoE*4 0.0805 0.0706 0.0755 0.0606 0.0500 0.0582
Genotype N % N % N % N % N % N %
E2/2 0 0 0 0 0 0 1 1.5 1 1.25 2 1.4
E3/2 23 13.2 18 10.2 41 11.7 1 1.5 7 8.75 8 5.5*
E3/3 125 71.8 135 76.3 260 74.1 57 86.4 66 82.5 123 84.2*
E4/2 2 0.6 6 3.4 8 2.3 1 1.5 0 0 1 0.68
E4/3 22 12.6 17 9.6 39 11.1 6 7.6 3 3.75 8 5.5
E4/4 2 0.6 1 0.5 3 0.85 1 1.5 3 3.75 4 2.7
*p<0.05
Deviation from the Hardy-Weinberg equilibrium in
the Romany sample is difficult to explain. Genotyping er-
ror is unlikely, because the same method was used for de-
tection and the same person detected the genotypes. In
an inbred population, the low proportion of heterozygous
may be due to inbreeding. However, the inbreeding coef-
ficient estimated in this sample (0.00016) is one and two
orders of magnitude lower than the values estimated in
other highly endogamous and inbred Romany groups
from Slovakia (e.g. in Podhorany, East Slovakia, F=
0.0065, and in the Walachian group, West Slovakia, F=
0.017)29,30. The value of F obtained in this sample falls
within the range reported for large populations in Eu-
rope (range from 0.00001 to 0.00077 in the second half of
the 20th century)31. Thus, it seems that it is sample size
rather than consanguinity that is responsible for the ob-
served deviation, for in our previous paper the same Ro-
many sample was in genetic equilibrium with respect to
another polymorphic system17.
The Apo E allele frequencies in the Slovak sample are
similar to those found in southern rather than central
Europe. The allele E*4 in southern Europe ranges from
0.069 in Turkey to 0.091 in Spain, the allele E*3 from
0.856 in Spain to 0.876 in Greece. The allele E*2 is similar
to the frequency in Turkey (0.067) or in Spain (0.065)4,6,32.
On the other hand, in central Europe the frequency of
the allele E*4 is generally over 10% and ranges from
0.107 in Switzerland to 0.163 in Belgium, while the allele
E*3 ranges from 0.752 in Netherlands to 0.807 in Hun-
gary. The allele E*2 attains the highest frequency in
France (0.106) and the lowest in Finland (0.043)6,33.
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TABLE 3
LIPID AND LIPOPROTEIN LEVELS ACCORDING TO APOE GENOTYPE GROUPS IN THE SLOVAK MALES, FEMALES, TOTAL SLOVAK
AND ROMANY SAMPLES (EXPRESSED AS X AND 95% CI)
Genotype Group E2 E3 E4 p
Slovak Males N=23 N=125 N=24
TC (mmol/L) 5.4 (4.9–5.8) 5.9 (5.7–6.1) 5.8 (5.3–6.3) 0.230
HDL-C (mmol/L) 1.4 (1.2–1.6) 1.3 (1.2–1.4) 1.3 (1.2–1.5) 0.399
TG (mmol/L) 2.7 (1.2–3.6) 2.2 (1.9–2.5) 1.3 (1.0–1.6) 0.009
LDL-C (mmol/L) 2.9 (2.5–3.4) 3.6 (3.4–3.8) 3.9 (3.5–4.3) 0.008
TC/HDL-C 4.1 (3.5–4.6) 4.9 (4.5–5.1) 4.5 (4.0–5.0) 0.056
log(TG/HDL-C) 0.09 (–0.06–0.23) 0.14 (0.08–0.20) –0.06 (–0.17–0.04) 0.024
Slovak Females N=18 N=135 N=18
TC (mmol/L) 6.4 (4.5–8.3) 5.9 (5.7–6.0) 6.1 (5.5–6.6) 0.451
HDL-C (mmol/L) 1.6 (1.4–1.8) 1.5 (1.5–1.6) 1.5 (1.3–1.7) 0.571
TG (mmol/L) 2.6 (–0.2–5.4) 1.5 (1.3–1.6) 1.8 (1.4–2.2) 0.130
LDL-C (mmol/L) 3.7 (2.8–4.6) 3.7 (3.5–3.8) 3.7 (3.3–4.2) 0.567
TC/HDL-C 3.6 (3.1–4.1) 4.5 (3.6–5.4) 4.3 (3.5–5.0) 0.322
log(TG/HDL-C) –0.14 (–0.27–(–0.01)) –0.05 (–0.10–(–0.00)) 0.02 (–0.13–0.18) 0.252
All Slovaks N=41 N=260 N=42
TC (mmol/L) 5.9 (5.0–6.7) 5.9 (5.7–6.0) 5.9 (5.6–6.3) 0.165
HDL-C (mmol/L) 1.5 (1.4–1.7) 1.4 (1.4–1.5) 1.4 (1.3–1.5) 0.551
TG (mmol/L) 2.5 (1.2–3.8) 1.8 (1.7–2.0) 1.5 (1.2–1.7) 0.405
LDL-C (mmol/L) 3.3 (2.8–3.7) 3.6 (3.5–3.8) 3.8 (3.5–4.1) 0.012
TC/HDL-C 3.9 (3.5–4.2) 4.7 (4.2–5.1) 4.4 (4.0–4.8) 0.077
log(TG/HDL-C) –0.01 (–0.11–0.09) 0.04 (–0.00–0.08) –0.03 (–0.11–0.06) 0.391
All Romany N=10 N=123 N=12
TC (mmol/L) 4.9 (3.5–6.3) 4.9 (4.7–5.1) 5.0 (4.6–5.5) 0.627
HDL-C (mmol/L) 1.0 (0.9–1.2) 1.0 (1.0–1.1) 1.04 (1.0–1.1) 0.401
TG (mmol/L) 3.6 (–1.1–8.4) 1.9 (1.6–2.2) 2.2 (1.3–3.0) 0.419
LDL-C (mmol/L) 2.6 (1.8–3.3) 3.0 (2.8–3.1) 3.2 (2.8–3.6) 0.258
TC/HDL-C 5.6 (2.2–8.9) 4.6 (4.4–4.9) 4.9 (4.2–5.6) 0.507
log(TG/HDL-C) 0.27 (–0.11–0.65) 0.14 (0.09–0.20) 0.26 (0.08–0.43) 0.390
TC – total cholesterol, LDL-C – low-density lipoprotein cholesterol, HDL-C – high-density lipoprotein cholesterol, TG – triglycerides,
TC/HDL-C and log(TG/HDL-C) – atherogenic indices
The allele frequencies in the Romany sample are simi-
lar to those reported e.g. from Sardinia (E*2=0.050, E
*3=0.898, E*4=0.052)4 and from different Indian groups
for which relatively low frequency of the alleles ApoE*4
and ApoE*2, respectively (E*2=0.030–0.070, E*4=0.055–
0.080), and high frequency of the allele ApoE*3 are char-
acteristic (E*3=0.875–0.889)6,33. However, our Romany
sample differs remarkably from the frequencies recorded
in Hungarian Gypsy children (ApoE*2=0.089, ApoE*3=
0.738 and ApoE*4=0.173)34.
The impact of ApoE genotype groups on quantitative
levels of lipids in the Slovak males, females and the total
Slovak and Romany samples is shown in Table 3. Since
no significant differences were observed in any plasma
lipids between genotype groups in the Romany males
and females, only results for the total sample are pre-
sented. However, even in the total sample no significant
association has been revealed, though the Romany E2
carriers showed lower LDL-C and TC levels than the E3
and E4 subjects. In the total Slovak sample only the
value related to LDL-C appeared significant among the
three-genotype groups (p=0.012). Particularly the Slo-
vak males contributed to this result since the E2 carriers
presented the lowest values and the E4 carriers the
greatest values of LDL-C (p=0.008). In this case also TG
levels showed association with apoE genotypes (p=
0.009); the E4 carriers have the lowest values and the E2
genotype group the highest values of plasma TG. In
males the three-genotype groups differ significantly (p=
0.024) in the value of log(TG/HDL-C).
The associations between the allele E*2 and decrea-
sed LDL-C and TC levels and increased HDL-C level and
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TABLE 4






Coefficient 95% CI p
TC
Age 0.029 (0.017–0.042) <0.001
Sex 0.209 (–0.018–0.435) 0.071
Ethnicity 1.419 (0.921–1.916) <0.001
ApoE 0.017 (–0.166–0.199) 0.859
BMI 0.014 (–0.011–0.040) 0.270
WHR 0.027 (0.019–0.034) <0.001
Education 0.054 (–0.183–0.292) 0.655
LDL-C
Age 0.019 (0.008–0.029) <0.001
Sex 0.186 (0.009–0.362) 0.039
Ethnicity 0.670 (0.286–1.054) 0.001
ApoE 0.020 (–0.122–0.162) 0.784
BMI 0.017 (–0.003–0.37) 0.094
WHR 0.015 (0.009–0.021) <0.001
Education 0.028 (–0.157–0.212) 0.768
HDL-C
Age 0.001 (–0.003–0.004) 0.768
Sex 0.093 (0.014–0.172) 0.021
Ethnicity –1.080 (–1.626–(–0.534)) <0.001
ApoE –0.001 (–0.050–0.049) 0.983
BMI –0.013 (–0.020–(–0.006)) <0.001
WHR –0.009 (–0.016–(–0.003)) 0.005
Education –0.006 (–0.072–0.060) 0.858
TG
Age 0.024 (0.004–0.043) 0.016
Sex –0.635 (–0.982–(–0.288)) <0.001
Ethnicity 0.508 (–0.254–1.269) 0.191
ApoE 0.054 (–0.225–0.334) 0.703
BMI 0.032 (–0.008–0.071) 0.113
WHR 0.004 (–0.007–0.015) 0.464
Education –0.025 (–0.389–0.338) 0.891
TC – total cholesterol, LDL-C – low-density lipoprotein cholesterol, HDL-C – high-density lipoprotein cholesterol, TG – triglycerides,
BMI – body mass index, WHR – waist to hip ratio
between the allele*4 and increased total-C and LDL-C
levels have been determined in many studies independ-
ently of ethnic group3,35.
In our study we did not confirm such association
among the Roma subjects though the tendency to lower
LDL-C in the E2 carrier was suggested. A remarkably
different effect of apoE genotypes on serum lipid parame-
ters was revealed in the Hungarian Gypsy children34.
They had significantly lower TC, LDL-C and TG levels in
the E3 genotype group than in the E2 and E4 groups.
Only the HDL-C levels did not differ significantly among
the genotype groups, as in our Romany sample. In the
Slovak sample a significant effect of apoE genotypes on
lipid levels was revealed only in males and the total sam-
ple. An interaction of sex with the effects of apoE poly-
morphism was recorded also in Spain – in women it influ-
enced plasma cholesterol, LDL and HDL levels, whereas
in men polymorphism was associated with variations in
TG and VLDL lipid levels36.
Differences between the sexes, as in our sample, have
also been found in the Czech population where the ApoE*4
allele was associated with higher TC and LDL-C levels
only in males37. On the other hand, in a Mexican popula-
tion this effect was observed only in female carriers of
the E3/4 genotype38.
No association between the ApoE genotypes and indi-
ces of obesity (BMI and WHR), were revealed either in
the Slovak or in the Romany subjects (data not shown).
The results on regression analysis of selected con-
founders with lipid and lipoprotein levels in the Romany
and Slovak study subjects are in Table 4. Significant as-
sociation was recorded with total cholesterol and age
(p<0.001), ethnicity (p<0.001) and WHR (p<0.001). Si-
milarly the level of LDL-C interacts with age (p<0.001),
ethnicity (p=0.001), WHR (p<0.001) and in addition
with sex (p=0.039). Significant positive association was
recorded between HDL-C and sex (p=0.021), and nega-
tive with ethnicity (p<0.001), BMI (p<0.001) and WHR
(p=0.005). The level of TG is associated significantly
with age (p=0.016) and sex (p<0.001).
Because in the analysis the variable sex indicates
male as (1) and female as (2) the result suggests that fe-
males had higher LDL-C and HDL-C than males and TG
are higher by males (–0.635). Interaction with ethnicity
(Slovak=1, Roma=2) shows that Roma subjects had
higher levels of TC and LDL-C and lower HDL-C. High
level of TC is influenced by high value of WHR index,
while the high level of HDL-C is influenced by lower val-
ues of WHR and BMI indices.
The regression analysis showed no significant associ-
ation of ApoE genotypes and level of education with
lipids and lipoproteins.
In conclusion, our data suggested differences between
ethnic samples in genetic variation at the ApoE locus. We
did not determine an effect of ApoE polymorphism on
lipid levels in the Romany subjects. In view of conven-
tional risk factors for cardiovascular disease the studied
subjects possess a different risk factor profile. The Roma
subjects have risky HDL-C and obesity markers (BMI
and WHR), and the Slovaks LDL-C and blood pressure.
The studied samples differ in predisposition to the insu-
lin resistance status, too. However, to detect the effective
role of any single genetic factor in determining the vari-
able or disease prevalence in a population, will depend
partly on the gene’s frequency and partly on the gene’s
interactions with other genetic and environmental fac-
tors. Because this is the first epidemiological study
among Roma people in Slovakia dealing with relation of
lipid profile and ApoE genotypes, further studies on risk
factors could be clarified on a larger sample and through
the analysis of different apolipoprotein loci39,40 that are
thought to be involved in susceptibility to cardiovascular
disease as suggested by other authors.
R E F E R E N C E S
1. MAHLEY, R. W., Science, 240 (1988) 622. — 2. UTERMANN, G.,
M. HEES, A. STEINMETZ, Nature, 269 (1977) 604. — 3. HALLMAN, D.
M., E. BOERWINKLE, N. SAHA, C. SANDHOLZER, H. J. MENZEL, A.
CZARAR, G. UTERMANN, Am. J. Hum. Genet., 49 (1991) 338. — 4.
CORBO, R. M., R. SCACCHI, L. MUREDDU, G. MULAS, S. CASTRE-
CHINI, P. RIVASI, Hum. Biol., 71 (1999) 933. — 5. GARCÉS, C., M. CAN-
TOS, M. BENAVENTE, J. J. GRANIZO, B. CANO, E. VITURRO, M. DE
OYA, Hum. Biol., 76 (2004) 615. — 6. SINGH, P., M. SINGH, U. GERDES,
S. S. MASTANA, Anthrop. Anz., 59 (2001) 27. — 7. DAVIGNON, J., R. E.
GREGG, C. F. SING, Atherosclerosis, 8 (1988) 1. — 8. RALL, S. C. JR., R.
W. MAHLEY, J. Intern. Med., 231 (1992) 633. — 9. ORDOVAS, J. M., L. A.
CUPPLES, P. W. WILSON, C. LAHOZ, D. LEVY, J. D. OTVOS, J. R. MC-
NAMARA, E. GAGNE, M. HAYDEN, E. SHAEFER, Atherosclerosis, 11
(1998) 425. — 10. WHO: World Health Statistic Annual. (Geneva, 1995).
— 11. EGNEROVÁ, A., A. BEZE^NÁ, Lek Obz, 46 (1997) 1. — 12. RA-
[LOVÁ, K., B. SMOLKOVÁ, J. FROHLICH, Atherosclerosis, 134 (1997)
67. — 13. RA[LOVÁ, K., A. BEDEROVÁ, J. GA[PAROVI^, P. BLA@Í-
^EK, B. SMOLKOVÁ, Physiol. Res., 49 (2000) 651. — 14. RA[LOVÁ, K.,
B. SMOLKOVÁ, B. VOHNOUT, J. GA[PAROVI^, J. FROHLICH, Metab-
olism, 50 (2001) 24. — 15. DOBIÁ[OVÁ, M., K. RA[LOVÁ, K. RAUCHO-
VÁ, B. VOHNOUT, K. PTÁ^KOVÁ, J. FROLICH, Physiol. Res., 50 (2001)
1. — 16. ZACHAROVÁ, M., K. RA[LOVÁ, J. KRAJ^OVI^, B. VOHN-
OUT, M. AVDI^OVÁ, Bull. Slov. antropol. Spolo~., 3 (2000) 80. — 17.
GA[PAROVI^, J., K. RA[LOVÁ, Z. BA[ISTOVÁ, M. ZACHAROVÁ, L.
WSÓLOVÁ, M. AVDI^OVÁ, P. BLA@Í^EK, J. LIETAVA, D. SIVÁKOVÁ,
Physiol. Res., 53 (2004) 218. — 18. GINTER, E., M. KRAJ^OVI^OVÁ-
KUDLÁ^KOVÁ, O. KA^ALA, V. KOVA^IC, M. VALACHOVI^OVÁ, Bra-
tisl. Lek Listy, 102 (2001) 479. — 19. BERNASOVSKÝ, I., J. BERNASOV-
SKÁ: Anthropology of Romanies (Gypsies). (NAUMA and Universitas
Masarykiana, Brno, 1999). — 20. MASTANA, S. S., S. S., PAPIHA, Z.
Morph. Anthrop., 79 (1992) 43. — 21. AVDI^OVÁ, M., A. EGNEROVÁ, F.
HRUBÁ: Evaluation of the CINDI program in Slovakia. (State Institute
of Public Health, Banská Bystrica, 2000). — 22. FRIEDEWALD, W. T., R.
L. LEVY, D. S. FREDRICKSON, Clin. Chem., 18 (1972) 499. — 23. DO-
BIÁ[OVÁ, M., J. FROHLICH, G. LUC, A. MYDLILOVÁ, J. PITHA, R.
POLEDNE, K. RA[LOVÁ, M. [AMÁNEK, Z. URBANOVÁ, Cardiol., 11
(2002) K/C 3A. — 24. HIXSON, J. E., D. T. VERNIER, J. Lipid. Res., 31
(1990) 545. — 25. RA[LOVÁ, K., S. FILIPOVÁ, Z. MIKE[, I. TKÁ^, J.
TURAY, Interná Medicína, 3 (2003) 10. — 26. GEROVÁ, Z., I. PANÁKO-
VÁ, M. MATU[KOVÁ, Bratisl Lek Listy, 100 (1999) 231. — 27. ZACHA-
ROVÁ, M., K. RA[LOVÁ, M. AVDI^OVÁ, D. Siváková, Bull. Slov. Antro-
pol. Spolo~., 5 (2002) 136. — 28. KRAJ^OVI^OVÁ-KUDLÁ^KOVÁ, M.,
P. BLA@Í^EK, V. SPUSTOVÁ, M. VALACHOVI^OVÁ, E. GINTER, Bra-
tisl Lek Listy, 105 (2004) 256. — 29. CHLEBOVSKÁ, K., I. BERNASOV-
D. Siváková et al.: Apolipoprotein E and Plasma Lipids in Slovakia, Coll. Antropol. 30 (2006) 2: 387–394
393
SKÝ, J. BERNASOVSKÁ, Bull. Slov. Antropol. Spolo~., 1 (1998) 49. — 30.
FERÁK, V., D. SIVÁKOVÁ, Z. SIEGLOVÁ, Bratisl Lek Listy, 87 (1987)
168. — 31. VOGEL, F., A. G. MOTULSKY: Human Genetics. (Springer-
-Verlag, Berlin, Heidelberg, New York, 1979). — 32. AL-BUSTAN, S. A.,
M. A. ALNAQEEB, B. C. ANNICE, G. IBRHIM, J. AL-RUBAIAN, A. H.
AHMED, T. M. REFAI, Hum. Biol., 77 (2005) 487. — 33. THELMA, B. K.,
R. C. JUYAL, H. H. DODGE, R. PANDAV, V. CHANDRA, M. GANGULI,
Hum. Biol., 73, (2001) 135. — 34. SZALAI, C., A. CZINNER, A. CSÁSZÁR,
Eur. J. Pediatrics, 159 (2000) 257. — 35. LARSON, I. A., J. M. ORDOVAS,
C. DE LUCA, Atherosclerosis, 148 (2000) 327. — 36. GOMEZ-CORONA-
DO, D., J. J. LVAREZ, A. ENTRALA, Atherosclerosis, 147 (1999) 67. —
37. HUBÁ^EK, J. A., D. M. WATERWORTH, R. POLEDNE, J. PITHA, Z.
[KODOVÁ, S. E. HUMPHRIES, P. J. TALMUD, Clin. Biochem., 34 (2001)
113. — 38. GAMBOA, R., G. VARGAS-ALARCÓN, A. MEDINA-URRU-
TIA, G. CARDOSO-SALDANA, G. HERNÁDEZ-PACHECO, J. ZAMORA-
-GONZÁLES, C. POSADAS-ROMERO, Hum. Biol., 73 (2001) 835. — 39.
CALO, C. M., L. VARESI, M. MEMMI, P. MORAL, G. VONNA, Coll. An-
tropol., 27 (2003) 105. — 40. AGARWAL, D. P., I. J. H. G., 1 (2001) 233.
D. Siváková et al.: Apolipoprotein E and Plasma Lipids in Slovakia, Coll. Antropol. 30 (2006) 2: 387–394
394
D. Siváková
Department of Anthropology, Faculty of Sciences, Comenius University, Mlynská dolina B2, 842 15 Bratislava 4,
Slovak Republic
e-mail: sivakova@fns.uniba.sk
POLIMORFIZAM APOLIPOPROTEINA E U ODNOSU NA RAZINU LIPIDA U PLAZMI I DRUGE
FAKTORE RIZIKA ZA ATEROSKLEROZU U DVIJE ETNI^KE SKUPINE IZ SLOVA^KE
S A @ E T A K
Utjecaj genotipova apolipoproteina E (apoE) na lipide u plazmi te interakcija s drugim okoli{nim faktorima odre|eni
su u dvije slova~ke populacije; 146 Roma i 351 Slovaka. Ove dvije populacije zna~ajno se razlikuju u raspodjeli geno-
tipova E3/3 (p	0.014) i E3/2 (p	0.035). Analiza varijance nije pokazala nikakav zna~ajni u~inak ApoE genotipova na
razinu bilo kojeg lipida u plazmi u romskoj populaciji. U populaciji Slovaka varijacije u razini kolesterola lipoproteina
niske gusto}e (LDL-C) zna~ajno su povezane s ApoE genotipovima (p=0.012). Uo~ili smo smanjenu koncentraciju LDL-
-C kod mu{karaca s E2 genotipom u usporedbi s nositeljima E3 i E4 genotipova (p=0.008). Nadalje, utvr|ena je po-
vezanost E2 genotipa s povi{enom razinom triglicerida u plazmi (p=0.009). Dvije etni~ke skupine zna~ajno se razlikuju
u prevalenciji metaboli~kog sindroma i dijabetesa kod mu{karaca. U obje skupine, i kod Roma i kod Slovaka, mu{karci
pokazuju ve}u sklonost aterosklerozi u usporedbi sa `enama.
